Dear AuntMinnieEurope Member,
Breast cancer screening has taken a back seat in Europe since the COVID-19 outbreak began in February, but it was back in the news this week.
A large U.K. study has provided evidence of the long-term risk of invasive disease after a diagnosis of ductal carcinoma in situ (DCIS), and the findings are set to contribute toward future guidance for surveillance of women. The authors emphasize that women diagnosed with DCIS generally have a very good prognosis, but those women still have an increased risk of developing invasive breast cancer, and they must continue to attend breast screening. Learn more in the Women's Imaging Community.
The difficulties of guaranteeing quality in prostate MRI have held back the clinical implementation of the technique in recent years, but the signs are that leading European radiologists and urologists are getting their act together. A new consensus paper seems to represent a significant breakthrough. Visit the MRI Community to read more.
Dr. Giles Maskell's columns have become essential reading for many of you. Up until this point, he had resisted the temptation to write about the pandemic, but now he's shared his views in a clearly written and well-argued piece that reflects on the post-COVID-19 challenges facing radiology.
Meanwhile, the congress schedule shows no sign of getting back on track. The organizers have made an early announcement that the RSNA won't take place onsite in late November. Instead, it will be a fully virtual meeting.
Machine learning based on functional MRI data is showing great promise as a tool to assess the prognoses of comatose patients. A research team from Geneva University Hospitals in Switzerland published its findings on 21 May in the American Journal of Neuroradiology, and they're worth a close look in the Artificial Intelligence Community.
